Janus Henderson Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Janus Henderson Group’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,203	Closed	-$1.09M	–	2727
2023 Q1	$1.09M	Buy	10,203 +5,617	+122%	+$647K	﹤0.01%	1581
2022 Q4	$504K	Buy	+4,586	New	+$297K	﹤0.01%	1714

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Janus Henderson Group's RXDX Position: Q2 2023 in Review

Janus Henderson Group sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 10,203 shares — an estimated $1.09M sold.

Janus Henderson Group first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $1.09M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Janus Henderson Group reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Janus Henderson Group sold 10,203 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $1.09M.
Janus Henderson Group first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Janus Henderson Group's Prometheus Biosciences, Inc. Common Stock position peaked at $1.09M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.